Business Development Director EUROPE (m/f/d) – Reproductive Genetics jobs in United States
cer-icon
Apply on Employer Site
company-logo

CENTOGENE · 3 days ago

Business Development Director EUROPE (m/f/d) – Reproductive Genetics

CENTOGENE is a truly international company focused on advancing diagnostic solutions for patients with rare diseases. They are seeking a highly experienced Business Development Director to lead and expand commercial activities in Reproductive Genetics across Europe, driving revenue growth and developing strategic partnerships.

BiotechnologyClinical TrialsGeneticsHealth CareHealth Diagnostics

Responsibilities

Develop and execute the commercial and business development strategy for Reproductive Genetics in Europe or assigned territories
Drive growth of the reproductive genetics portfolio
Identify, establish, and manage strategic partnerships with IVF clinics, hospitals, laboratories, and key opinion leaders
Lead negotiations and closing of high-value commercial agreements
Analyze market trends, competitive landscape, and customer needs to identify new business opportunities
Collaborate closely with internal teams (medical, marketing, operations, and customer support) to ensure successful implementation of commercial strategies
Represent the company at international congresses, conferences, and industry events
Manage key accounts and ensure high levels of customer satisfaction and long-term collaboration
Prepare commercial forecasts, reports, and performance metrics for senior management

Qualification

Business developmentReproductive GeneticsStrategic partnershipsSales leadershipNegotiation skillsCommunication skillsFluent EnglishTime managementInterpersonal skillsStrategic thinking

Required

Minimum 5 years of experience in business development, sales, or commercial leadership, preferably within genetics, IVF, reproductive medicine, or life sciences
Proven experience managing European markets or multi-country territories
Strong knowledge of Reproductive Genetics, PGT-A, PGT-M, PGT-SR, Carrier Screening
Demonstrated success in building and growing complex B2B partnerships
Excellent negotiation, communication, and presentation skills
High level of scientific and clinical understanding, with the ability to communicate complex concepts clearly to non-technical stakeholders
Fluent English (written and spoken) – mandatory
Full availability to travel extensively across Europe

Preferred

Additional European languages are a strong plus

Benefits

Competitive compensation package, including performance-based incentives

Company

CENTOGENE

company-logo
CENTOGENE provides methods and technology for human genetics analysis.

Funding

Current Stage
Public Company
Total Funding
$224.93M
Key Investors
LiferaOxford Finance LLCTVM Capital Life Science
2023-06-28Post Ipo Debt· $30M
2022-02-01Post Ipo Equity· $16.91M
2022-02-01Post Ipo Debt· $45M

Leadership Team

leader-logo
Peter Bauer
Chief Scientific Officer
linkedin
Company data provided by crunchbase